[BIO-B] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
27-Oct-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 109.14%
YoY- 164.70%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 632,124 680,800 747,049 647,263 560,633 545,138 535,003 2.81%
PBT 137,102 -209,168 5,022,226 1,684,461 -335,216 350,131 38,855 23.37%
Tax 30,845 -44,936 1,094,193 369,637 -76,400 80,805 11,462 17.92%
NP 106,257 -164,232 3,928,033 1,314,824 -258,816 269,326 27,393 25.33%
Tax Rate -22.50% - -21.79% -21.94% - -23.08% -29.50% -
Total Cost 525,867 845,032 -3,180,984 -667,561 819,449 275,812 507,610 0.59%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 16.81 -24.12 525.81 203.14 -46.16 49.41 5.12 21.90%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS 3.65 -5.53 131.75 44.24 -8.68 9.02 0.74 30.45%
EPS Diluted 3.64 -5.52 129.96 43.64 -8.68 8.89 0.73 30.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.